Page last updated: 2024-08-23

phenyl acetate and Atherosclerosis

phenyl acetate has been researched along with Atherosclerosis in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (6.25)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (27.08)	29.6817
2010's	26 (54.17)	24.3611
2020's	6 (12.50)	2.80

Authors

Authors	Studies
Li, C; Liu, Z; Qie, R; Suo, Q; Wang, H; Yang, J; Zhou, Y	1
Recatalá, CA; Santoro, MM	1
Barg, E; Bodetko, A; Hetman, M; Mielko, K; Młynarz, P; Placzkowska, S	1
Gillard, BK; Gotto, AM; Pownall, HJ; Rosales, C	1
Boscá, L; Fernández-García, V	1
Hellberg, S; Jauhiainen, M; Knuuti, J; Li, XG; Liljenbäck, H; Metsälä, O; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Ståhle, M; Virta, J; Ylä-Herttuala, S	1
Asada, Y; Kawai, K; Kuge, Y; Nishii, R; Shimizu, Y; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y	1
Arnaud, C; Arnol, N; Bäck, M; Belaïdi, E; Gautier-Veyret, E; Lévy, P; Pépin, JL; Perrin, M; Stanke-Labesque, F; Tamisier, R	1
Aiyer, A; Asp, P; Barahman, M; Beck, AP; Guha, C; Harris, HY; Kabarriti, R; Kinkhabwala, M; Roy-Chowdhury, J; Roy-Chowdhury, N; Scanlan, TS; Zhang, W	1
Abdallah, M; Abi Rafeh, N; Bhat, T; El-Sayegh, S; Kalantar-Zadeh, K; Khoueiry, G; Lafferty, J; Raza, M; Saiful, F	1
Behrendt, M; Dikkers, A; Gautier, T; Grass, DS; Hurt-Camejo, E; Rader, DJ; Rosengren, B; Tietge, UJ	1
Bash, D; Brennan, DM; Cavender, MA; Jukema, JW; Kastelein, JJ; Koenig, W; Lincoff, AM; Menon, V; Nambi, V; Nicholls, SJ; Nissen, SE; Rosenson, RS; Schwartz, GG; Wright, RS	1
Chew, GT; Sahebkar, A; Watts, GF	1
Eggertsen, G; Gåfvels, M; Kannisto, K; Larsson, L; Parini, P; Rehnmark, S; Slätis, K; Webb, P	1
Corsini, A; Ferri, N	1
Gotto, AM; Pownall, HJ	1
Bai, Y; Chang, CC; Chang, TY; Chen, S; Li, BL; Li, L; Liu, W; Liu, X; Meng, X; Song, BL; Sun, SC; Wang, J; Wang, L; Xiong, Y; Xu, C; Yan, C; Yang, W; Zhang, J; Zhang, T; Zheng, X; Zhou, P	1
Chen, L; Qi, X; Qian, H; Shen, Y; Wang, L; Zhang, H; Zhang, Y	1
Di, X; Tang, X	1
Bjorndahl, TC; Caplice, NM; Fitzgerald, GF; London, LE; Mandal, R; Murphy, K; Ross, RP; Ryan, PM; Shanahan, F; Stanton, C; Wishart, DS	1
Gajda, M; Jawien, J; Korbut, R; Olszanecki, R; Wołkow, P; Zurańska, J	1
Fraser, H; Lusis, AJ; Shaposhnik, Z; Trias, J; Wang, X	1
Cheng, S; Ge, S; Liu, D; Liu, X; Xu, G; Xu, J; Zhou, G	1
Chouinard, ML; Christie, RM; Eacho, PI; Fraser, H; Gould, KE; Hislop, C; Reidy, CA; Rick, HL; Trias, J	1
Fernandez, ML; Fraser, H; Leite, JO; Puglisi, M; Trias, J; Vaishnav, U	1
Garcia-Garcia, HM; Serruys, PW	1
Suckling, KE	1
Eller, P; Patsch, JR; Ritsch, A; Tancevski, I	1
Cheng, S; Ge, S; Liu, D; Liu, X; Liu, Z; Xu, G; Zhang, R; Zhou, G; Zhu, W	1
Basford, JE; Durand, JL; Factor, SM; Hofmann, SM; Hui, DY; Jelicks, LA; Kuriakose, G; Nawrocki, AR; Scherer, PE; Tabas, I; Tanowitz, HB; Teupser, D; Woo, CW	1
Suckling, K	1
Cioffi, F; Goglia, F; Lanni, A	1
Rosenson, RS	1
Fraser, H; Hislop, C; Rosenson, RS; Trias, J	1
Inazu, A	1
Busch, JD; Derlin, T; Habermann, CR; Lengyel, Z; Mester, J; Pávics, L; Wisotzki, C	1
Stiefelhagen, P	1
Choi, YJ; Geaney, JC; Karpf, DB; Krauss, RM; Naim, S; Roberts, BK; Wang, X; Wojnoonski, K	1
Hurt-Camejo, E; Rosenson, RS	1
Abatepaulo, F; Bet, AC; DalBó, S; de Souza, HP; Hort, MA; Ianssen, C; Maraschin, M; Ribeiro-do-Valle, RM; Schuldt, EZ; Siqueira, JM; Veleirinho, B	1
Baldus, S; Böger, RH; Carrier, L; Donzelli, S; DuMond, JF; Eschenhagen, T; Espey, MG; Fischer, G; Gerloff, C; Heeren, J; King, BS; Niemann, C; Wieboldt, H	1
BALAGUER-VINTRO, I; DE ORUS-NAVARRO, J; GIBERT-QUERALTO, J; MENINI, E; NOLLA-PANADES, J	1
CERQUA, R; ORIENTE, P; PORRAZZI, LC; ROSSI, GB; VECCHIONE, A	1
NATH, MC; SAIKIA, A	1
Egido, J; Gómez-Gerique, JA; Gómez-Hernández, A; González, A; Ortega, L; Sánchez-Galán, E; Tuñón, J; Vidal, C	1
Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC	1
Balogh, Z; Fóris, G; Koncsos, P; Kosztáczky, B; Paragh, G; Seres, I; Zsiros, E	1
Badimon, JJ; Chew, DP; Corti, R; Fallon, JT; Fayad, ZA; Fuster, V; Helft, G; Worthley, MI; Worthley, SG; Zaman, AG	1

Reviews

13 review(s) available for phenyl acetate and Atherosclerosis

Article	Year
The Alcohol-High-Density Lipoprotein Athero-Protective Axis. Biomolecules, 2020, 07-01, Volume: 10, Issue:7 Topics: Acetates; Alcohol Drinking; Atherosclerosis; Energy Metabolism; Humans; Lipoproteins, HDL	2020
High-density lipoprotein in uremic patients: metabolism, impairment, and therapy. International urology and nephrology, 2014, Volume: 46, Issue:1 Topics: Acetamides; Acetates; Acetyl-CoA C-Acetyltransferase; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Cholesterol; Cholesterol Ester Transfer Proteins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins, HDL; Niacin; PPAR alpha; Quinolines; Renal Insufficiency, Chronic; Sulfonamides; Sulfonic Acids; Uremia	2014
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:4 Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides	2014
[Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk]. Giornale italiano di cardiologia (2006), 2014, Volume: 15, Issue:12 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Acute Coronary Syndrome; Atherosclerosis; Benzaldehydes; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Humans; Indoles; Keto Acids; Lipoproteins; Oximes; Phospholipase A2 Inhibitors; Phospholipases A	2014
New Insights into the High-Density Lipoprotein Dilemma. Trends in endocrinology and metabolism: TEM, 2016, Volume: 27, Issue:1 Topics: Acetates; Alcohols; Animals; Atherosclerosis; Cardiovascular Diseases; Dyslipidemias; Humans; Lipoproteins, HDL; Receptors, G-Protein-Coupled	2016
Phospholipase A2 inhibitors. Current opinion in lipidology, 2009, Volume: 20, Issue:4 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Animals; Atherosclerosis; Benzaldehydes; Blood Proteins; Humans; Indoles; Inflammation; Keto Acids; Oximes	2009
The resurgence of thyromimetics as lipid-modifying agents. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:9 Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones	2009
Phospholipase A2s: developing drug targets for atherosclerosis. Atherosclerosis, 2010, Volume: 212, Issue:2 Topics: Acetates; Animals; Atherosclerosis; Benzaldehydes; Biomarkers; Cytosol; Drug Design; Enzyme Inhibitors; Humans; Indoles; Keto Acids; Lipoproteins; Mice; Oximes; Phospholipase A2 Inhibitors; Phospholipases A2	2010
Thyroid hormones, mitochondrial bioenergetics and lipid handling. Current opinion in endocrinology, diabetes, and obesity, 2010, Volume: 17, Issue:5 Topics: Acetates; Adiposity; Anilides; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Diiodothyronines; Dyslipidemias; Energy Metabolism; Fatty Liver; Humans; Lipid Metabolism; Mice; Mitochondria; Obesity; Phenols; Rats; Thyroid Hormones	2010
Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes. Current opinion in lipidology, 2010, Volume: 21, Issue:6 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Animals; Atherosclerosis; Benzaldehydes; Biomarkers; Controlled Clinical Trials as Topic; Disease Models, Animal; Dosage Forms; Humans; Indoles; Keto Acids; Mice; Mice, Transgenic; Molecular Targeted Therapy; Oximes; Phospholipases A2, Secretory; Risk Factors	2010
Varespladib methyl in cardiovascular disease. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:10 Topics: Acetates; Animals; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Indoles; Inflammation; Keto Acids; Male; Phospholipases A2, Secretory	2010
[Novel therapy for atherosclerosis and inflammatory vascular disease]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1 Topics: Acetates; Amides; Apolipoprotein A-I; Atherosclerosis; Benzaldehydes; Blood Proteins; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Drug Design; Esters; Humans; Indoles; Keto Acids; Molecular Targeted Therapy; Oxazolidinones; Oximes; Probucol; Quinazolines; Quinazolinones; Sulfhydryl Compounds	2011
Phospholipase A2 enzymes and the risk of atherosclerosis. European heart journal, 2012, Volume: 33, Issue:23 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Animals; Atherosclerosis; Benzaldehydes; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Enzyme Inhibitors; Guinea Pigs; Humans; Indoles; Keto Acids; Mice; Mutation, Missense; Myocardial Ischemia; Myocytes, Cardiac; Oximes; Phospholipases A2, Secretory; Polymorphism, Genetic; Risk Factors	2012

Trials

2 trial(s) available for phenyl acetate and Atherosclerosis

Article	Year
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA, 2014, Jan-15, Volume: 311, Issue:3 Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Heptanoic Acids; Humans; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2, Secretory; Pyrroles; Risk; Stroke; Survival Analysis; Treatment Outcome	2014
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. Atherosclerosis, 2012, Volume: 220, Issue:2 Topics: Acetates; Analysis of Variance; Atherosclerosis; Atorvastatin; Biomarkers; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Particle Size; PPAR gamma; Pyrroles; Time Factors; Treatment Outcome; Triazoles	2012

Article

Year

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

JAMA, 2014, Jan-15, Volume: 311, Issue:3

Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Heptanoic Acids; Humans; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2, Secretory; Pyrroles; Risk; Stroke; Survival Analysis; Treatment Outcome

2014

Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia.

Atherosclerosis, 2012, Volume: 220, Issue:2

Topics: Acetates; Analysis of Variance; Atherosclerosis; Atorvastatin; Biomarkers; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Particle Size; PPAR gamma; Pyrroles; Time Factors; Treatment Outcome; Triazoles

2012

Other Studies

33 other study(ies) available for phenyl acetate and Atherosclerosis

Article	Year
Ethyl acetate extract of Molecular omics, 2022, 12-05, Volume: 18, Issue:10 Topics: Acetates; Animals; Atherosclerosis; Caesalpinia; Mice; Mice, Knockout, ApoE; Plant Extracts; Rats	2022
The glucose-to-acetate metabolic flux that drives endothelial-to-mesenchymal transition via TGF-β signaling. Cell metabolism, 2023, 07-11, Volume: 35, Issue:7 Topics: Acetates; Atherosclerosis; Glucose; Humans; Transforming Growth Factor beta	2023
Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies. Pediatric endocrinology, diabetes, and metabolism, 2023, Volume: 29, Issue:3 Topics: Acetates; Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Child; Creatinine; Down Syndrome; Formates; Glutamine; Humans; Lysine; Proline; Pyrrolidonecarboxylic Acid; Risk Factors; Xanthines	2023
Use of Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:3 Topics: Acetates; Atherosclerosis; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
Evaluation of glucagon-like peptide-1 receptor expression in nondiabetic and diabetic atherosclerotic mice using PET tracer American journal of physiology. Endocrinology and metabolism, 2021, 05-01, Volume: 320, Issue:5 Topics: Acetates; Animals; Apolipoproteins B; Atherosclerosis; Diabetes Mellitus, Experimental; Exenatide; Female; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Heterocyclic Compounds, 1-Ring; Hypercholesterolemia; Insulin-Like Growth Factor II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Positron-Emission Tomography; Receptors, LDL	2021
In vitro uptake and metabolism of [ Nuclear medicine and biology, 2018, Volume: 56 Topics: Acetates; Animals; Arteries; Atherosclerosis; Carbon Radioisotopes; Cells, Cultured; In Vitro Techniques; Male; Rabbits	2018
Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome. Pharmacological research, 2018, Volume: 134 Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Adult; Animals; Arachidonate 5-Lipoxygenase; Atherosclerosis; Case-Control Studies; Cyclopropanes; Cysteine; Disease Models, Animal; Disease Progression; Female; Humans; Leukotriene Antagonists; Leukotriene E4; Leukotrienes; Male; Mice, Knockout, ApoE; Middle Aged; Plaque, Atherosclerotic; Quinolines; Receptors, Leukotriene; Risk Factors; Signal Transduction; Sleep Apnea, Obstructive; Sulfides	2018
Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis. Journal of hepatology, 2019, Volume: 70, Issue:6 Topics: Acetates; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Dyslipidemias; Female; Hepatocytes; Hyperlipoproteinemia Type II; Male; Mice; Mice, Inbred C57BL; Phenols	2019
Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:12 Topics: Acetates; Animals; Aorta; Aortic Diseases; Apolipoprotein E3; Apolipoproteins B; Atherosclerosis; Cholesterol Ester Transfer Proteins; Disease Models, Animal; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; Hypercholesterolemia; Indoles; Keto Acids; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Atherosclerotic	2013
The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice. Atherosclerosis, 2014, Volume: 237, Issue:2 Topics: Acetates; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Bile Acids and Salts; Biological Transport; Cholesterol; Disease Models, Animal; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenols; Phytosterols; Receptors, LDL; Sterols; Thyroid Hormone Receptors beta; Time Factors	2014
Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature, 2016, Mar-31, Volume: 531, Issue:7596 Topics: Acetamides; Acetates; Acetyl-CoA C-Acetyltransferase; Animals; Atherosclerosis; CD8-Positive T-Lymphocytes; Cell Membrane; Cholesterol; Esterification; Female; Immunological Synapses; Immunotherapy; Male; Melanoma; Mice; Programmed Cell Death 1 Receptor; Receptors, Antigen, T-Cell; Signal Transduction; Sulfonamides; Sulfonic Acids	2016
In Vitro and in Vivo antioxidant activity of ethyl acetate extraction of purple rice. Cellular and molecular biology (Noisy-le-Grand, France), 2016, Apr-30, Volume: 62, Issue:4 Topics: Acetates; Animals; Antioxidants; Atherosclerosis; Biphenyl Compounds; Chelating Agents; Diet; Fatty Liver; Free Radical Scavengers; Gene Expression Regulation; Iron; Lipids; Liver; Male; Mice; Oryza; Oxidation-Reduction; Phenols; Picrates; Real-Time Polymerase Chain Reaction	2016
Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis. Biochemical and biophysical research communications, 2017, 04-22, Volume: 486, Issue:1 Topics: Acetates; Anti-Asthmatic Agents; Atherosclerosis; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cells, Cultured; Cyclopropanes; Dose-Response Relationship, Drug; E-Selectin; Endothelium, Vascular; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Lipoproteins, LDL; Mitogen-Activated Protein Kinase 7; Molecular Structure; Monocytes; Protective Agents; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sulfides; Vascular Cell Adhesion Molecule-1	2017
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E Microbiome, 2017, 03-13, Volume: 5, Issue:1 Topics: Acetates; Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; beta-Glucans; Butyrates; Cardiovascular Diseases; Carnitine; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Dietary Supplements; Feces; Gastrointestinal Microbiome; Hemiterpenes; Limosilactobacillus reuteri; Male; Metabolome; Mice; Obesity; Pentanoic Acids; Probiotics	2017
The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008, Volume: 59, Issue:3 Topics: Acetates; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cholesterol; Cyclopropanes; Female; Leukotriene Antagonists; Lipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Quinolines; Receptors, LDL; Sulfides; Triglycerides	2008
The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002). Journal of lipid research, 2009, Volume: 50, Issue:4 Topics: Acetates; Animals; Apolipoproteins E; Aryldialkylphosphatase; Atherosclerosis; Drug Synergism; Enzyme Inhibitors; Indoles; Keto Acids; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipases A2, Secretory; Pravastatin; Prodrugs	2009
Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model. Atherosclerosis, 2009, Volume: 205, Issue:1 Topics: Acetates; Animals; Atherosclerosis; Atorvastatin; Carotid Arteries; Catheterization; Chemokine CCL2; Cyclopropanes; Diet, Atherogenic; Disease Progression; Heptanoic Acids; Immunohistochemistry; Leukotriene Antagonists; Lipids; Male; Pyrroles; Quinolines; Rabbits; Random Allocation; Sulfides	2009
Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice. Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:1 Topics: Acetates; Aneurysm; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Atherosclerosis; Blood Proteins; Cholesterol; Group II Phospholipases A2; Humans; Indoles; Keto Acids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phospholipases A2, Secretory	2009
A-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs. BMC cardiovascular disorders, 2009, Feb-17, Volume: 9 Topics: Acetates; Animals; Aorta, Thoracic; Atherosclerosis; Blood Proteins; Cholesterol; Diet, Atherogenic; Granulocyte-Macrophage Colony-Stimulating Factor; Guinea Pigs; Indoles; Interleukin-10; Interleukin-12; Keto Acids; Lipid Metabolism; Magnetic Resonance Imaging; Phospholipase A2 Inhibitors	2009
Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic. Expert opinion on investigational drugs, 2009, Volume: 18, Issue:10 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Animals; Atherosclerosis; Benzaldehydes; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Keto Acids; Oximes; Phospholipase A2 Inhibitors	2009
Montelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbits. Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:6 Topics: Acetates; Animals; Atherosclerosis; Atorvastatin; Cyclopropanes; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukotriene Antagonists; Lipids; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocytes, Smooth Muscle; Pyrroles; Quinolines; Rabbits; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Sulfides	2009
Lack of association between adiponectin levels and atherosclerosis in mice. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:6 Topics: Acetates; Adiponectin; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Female; Genotype; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phenotype; PPAR gamma; Receptors, LDL; Time Factors	2010
Feasibility of 11C-acetate PET/CT for imaging of fatty acid synthesis in the atherosclerotic vessel wall. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12 Topics: Acetates; Adult; Aged; Arteries; Atherosclerosis; Biological Transport; Calcinosis; Carbon Radioisotopes; Cohort Studies; Fatty Acids; Feasibility Studies; Female; Humans; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Reproducibility of Results; Risk Factors; Tomography, X-Ray Computed	2011
[Pathogenesis, diagnosis and therapy of bronchial asthma. How can the lungs be freed?]. MMW Fortschritte der Medizin, 2011, Jan-27, Volume: 153, Issue:4 Topics: Acetates; Administration, Inhalation; Adult; Airway Obstruction; Asthma; Atherosclerosis; Bronchodilator Agents; Bronchoscopy; Child; Cyclopropanes; Glucocorticoids; Humans; Hyperthermia, Induced; Leukotriene Antagonists; Quinolines; Scopolamine Derivatives; Sulfides; Tiotropium Bromide	2011
Anti-atherogenic effects of a phenol-rich fraction from Brazilian red wine (Vitis labrusca L.) in hypercholesterolemic low-density lipoprotein receptor knockout mice. Journal of medicinal food, 2012, Volume: 15, Issue:10 Topics: Acetates; Animals; Arteries; Atherosclerosis; Brazil; Cholesterol, HDL; Cholesterol, LDL; Diet; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Phenols; Receptors, LDL; Triglycerides; Vasodilation; Wine	2012
Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:2 Topics: Acetates; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Blood Platelets; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Half-Life; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Nitric Oxide Donors; Nitrogen Oxides; Nitroso Compounds; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilation; Vasodilator Agents	2013
Role of phenylethyl-acetic acid, linoleic acid and pyridoxine in experimental atherosclerosis in the chick. Acta cardiologica, 1958, Volume: 13, Issue:1 Topics: Acetates; Animals; Arteriosclerosis; Atherosclerosis; Chickens; Cholesterol; Linoleic Acid; Pyridoxine; Vitamin B 6	1958
DEOXYCORTICOSTERONE ACETATE AND EXPERIMENTAL ATHERO-SCLEROSIS IN CHOLESTEROL-FED RABBITS. Nature, 1964, Jul-18, Volume: 203 Topics: Acetates; Animals; Atherosclerosis; Cholesterol; Coronary Vessels; Desoxycorticosterone; Desoxycorticosterone Acetate; Diet, Atherogenic; Dietary Fats; Hyaluronoglucosaminidase; Pathology; Pharmacology; Rabbits; Research; Sclerosis	1964
The effect of different food fats on experimental atherosclerosis and the beneficial effect of essential fatty acids, vitamin B 12 and hydrolyzed glucose cyclo-acetoacetate. Archives of biochemistry and biophysics, 1959, Volume: 84 Topics: Acetates; Acetoacetates; Atherosclerosis; Fats; Fatty Acids; Fatty Acids, Essential; Glucose; Vitamin B 12	1959
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 320, Issue:1 Topics: Acetates; Animals; Atherosclerosis; Chemokine CCL2; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Leukotriene B4; Lipids; Lipoxygenase Inhibitors; Macrophages; Male; NF-kappa B; Pyrroles; Rabbits; RNA, Messenger; Thromboxane B2; Tunica Intima	2007
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation, 2007, Apr-10, Volume: 115, Issue:14 Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional	2007
Leptin stimulates endogenous cholesterol synthesis in human monocytes: New role of an old player in atherosclerotic plaque formation. Leptin-induced increase in cholesterol synthesis. The international journal of biochemistry & cell biology, 2007, Volume: 39, Issue:9 Topics: Acetates; Area Under Curve; Atherosclerosis; Calcium; Calcium Signaling; Carbon Radioisotopes; Case-Control Studies; Cholesterol; Demography; Female; Humans; Hypercholesterolemia; Inositol 1,4,5-Trisphosphate; Leptin; Male; Middle Aged; Monocytes	2007
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiology of haemostasis and thrombosis, 2007, Volume: 36, Issue:1 Topics: Acetamides; Acetates; Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Catheterization; Cholesterol; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Magnetic Resonance Imaging; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Pyrroles; Rabbits; Random Allocation; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids	2007